CD1-MR1 2025 , ,
Presentations this author is a contributor to:
Design of cytokine engineered invariant Natural Killer T (iNKT) cells for adoptive immunotherapy of cancer (#62)
12:15 PM
Gloria Delfanti
Therapy of Cancer and Other Diseases 1